Maria C. Vaccaro
University of Salerno
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Maria C. Vaccaro.
PLOS ONE | 2013
Antonio Vassallo; Maria C. Vaccaro; Nunziatina De Tommasi; Fabrizio Dal Piaz; Antonella Leone
Besides its function in normal cellular growth, the molecular chaperone heat shock protein 90 (Hsp90) binds to a large number of client proteins required for promoting cancer cell growth and/or survival. In an effort to discover new small molecules able to inhibit the Hsp90 ATPase and chaperoning activities, we screened, by a surface plasmon resonance assay, a small library including different plant polyphenols. The ellagitannin geraniin, was identified as the most promising molecule, showing a binding affinity to Hsp90α similar to that of 17-(allylamino)-17-demethoxygeldanamycin (17AGG). Geraniin was able to inhibit in vitro the Hsp90α ATPase activity in a dose−dependent manner, with an inhibitory efficiency comparable to that measured for 17-AAG. In addition, this compound compromised the chaperone activity of Hsp90α, monitored by the citrate synthase thermal induced aggregation assay. Geraniin decreased the viability of HeLa and Jurkat cell lines and caused an arrest in G2/M phase. We also proved that following exposure to different concentrations of geraniin, the level of expression of the client proteins c-Raf, pAkt, and EGFR was strongly down−regulated in both the cell lines. These results, along with the finding that geraniin did not exert any appreciable cytotoxicity on normal cells, encourage further studies on this compound as a promising chemical scaffold for the design of new Hsp90 inhibitors.
IEEE Transactions on Nanotechnology | 2013
Raffaele Di Giacomo; Bruno Maresca; Maurizio Angelillo; Giovanni Landi; Antonietta Leone; Maria C. Vaccaro; Christian Boit; Amalia Porta; Heinz C. Neitzert
Here, we report a procedure to obtain novel artificial materials using either fungal or isolated tobacco cells in association with different percentages of carbon nanotubes. The electrical, mechanical, and optical properties of these materials have been determined. The produced bio-nano-composite materials have linear electrical characteristics, high temperature stability up to 180 °C, linear increase of the electrical conductivity with increasing temperature and, in one case, also optical transparency. Using tobacco cells, we obtained a material with low mass density and mechanical properties suitable for structural applications along with high electrical conductivity. We also present theoretical models both for their mechanical and electrical behavior. These findings report a procedure for the next generation bio-nano-composite materials.
Chemistry: A European Journal | 2016
Maria Giovanna Chini; Nicola Malafronte; Maria C. Vaccaro; Maria J. Gualtieri; Antonio Vassallo; Michele Vasaturo; Sabrina Castellano; Ciro Milite; Antonietta Leone; Giuseppe Bifulco; Nunziatina De Tommasi; Fabrizio Dal Piaz
The identification of inhibitors of Hsp90 is currently a primary goal in the development of more effective drugs for the treatment of various types of multidrug resistant malignancies. In an attempt to identify new small molecules modulating the activity of Hsp90, we screened a small library of tetranortriterpenes. A high-affinity interaction with Hsp90 inducible form was uncovered for eight of these compounds, five of which are described here for the first time. By monitoring the ATPase activity and the citrate synthase thermal induced aggregation, compound 1 (cedrelosin A), 3 (7α-limonylacetate), and 5 (cedrelosin B), containing a limonol moiety, were found to be the most effective in compromising the Hsp90α chaperone activity. Consistent with these findings, the three compounds caused a depletion of c-Raf and pAkt Hsp90 client proteins in HeLa and MCF/7 cell lines. Induced fit docking protocol and molecular dynamics were used to rationalize the structural basis of the biological activity of the limonol derivatives. Taken together, these results point to limonol-derivatives as promising scaffolds for the design of novel Hsp90α inhibitors.
RSC Advances | 2016
Stefania Terracciano; Antonio Foglia; Maria Giovanna Chini; Maria C. Vaccaro; Alessio Russo; F. Dal Piaz; Carmela Saturnino; Raffaele Riccio; Giuseppe Bifulco; Ines Bruno
The inhibition of the C-terminal domain of heat shock protein 90 (Hsp90) is emerging as a novel strategy for cancer therapy, therefore the identification of a new class of C-terminal inhibitors is strongly required, also in consideration that to date only nature-inspired molecules have been largely expanded. Our recent discovery of potent antiproliferative dihydropyrimidone based C-terminal Hsp90 inhibitor (1, IC50 = 50.8 ± 0.2 μM and 20.8 ± 0.3 μM in A375 and Jurkat cell lines, respectively) drove us to further explore this very promising pharmacophoric core. In this study, we identified a new set of DHPM-derivatives that exhibited antiproliferative activity against two cancer lines by their modulation of Hsp90 C-terminus without inducing the undesired heat shock response. Our results strongly outline the high sensitivity of the Biginelli scaffold to structural decorations allowing us to point out also that small variations can deeply influence biological activity.
Chemical Communications | 2016
S. Teracciano; Maria Giovanna Chini; Maria C. Vaccaro; Maria Strocchia; Antonio Foglia; Antonio Vassallo; Carmela Saturnino; Raffaele Riccio; Giuseppe Bifulco; Ines Bruno
Hsp90 C-terminal modulation represents an attractive strategy for the development of potent and safer antitumor compounds. Continuing our investigation on DHPM type inhibitors here we report a new set of potent C-terminal ligands which allowed us to identify the key structural features crucial for the biological activity.
Journal of Organic Chemistry | 2017
Assunta D’Amato; Raffaele Volpe; Maria C. Vaccaro; Stefania Terracciano; Ines Bruno; Massimo Tosolini; Consiglia Tedesco; Giovanni Pierri; Paolo Tecilla; Chiara Costabile; Giorgio Della Sala; Irene Izzo; Francesco De Riccardis
Cyclic peptoids have recently emerged as important examples of peptidomimetics for their interesting complexing properties and innate ability to permeate biological barriers. In the present contribution, experimental and theoretical data evidence the intricate conformational and stereochemical properties of five novel hexameric peptoids decorated with N-isopropyl, N-isobutyl, and N-benzyl substituents. Complexation studies by NMR, in the presence of sodium tetrakis[3,5-bis(trifluoromethyl)phenyl]borate (NaTFPB), theoretical calculations, and single-crystal X-ray analyses indicate that the conformationally stable host/guest metal adducts display architectural ordering comparable to that of the enniatins and beauvericin mycotoxins. Similarly to the natural depsipeptides, the synthetic oligolactam analogues show a correlation between ion transport abilities in artificial liposomes and cytotoxic activity on human cancer cell lines. The reported results demonstrate that the versatile cyclic peptoid scaffold, for its remarkable conformational and complexing properties, can morphologically mimic related natural products and elicit powerful biological activities.
Scientific Reports | 2018
Stefania Terracciano; Alessandra Russo; Maria Giovanna Chini; Maria C. Vaccaro; Marianna Potenza; Antonio Vassallo; Raffaele Riccio; Giuseppe Bifulco; Ines Bruno
Heat shock protein 90 (Hsp90) is an ATP dependent molecular chaperone deeply involved in the complex network of cellular signaling governing some key functions, such as cell proliferation and survival, invasion and angiogenesis. Over the past years the N-terminal protein domain has been fully investigated as attractive strategy against cancer, but despite the many efforts lavished in the field, none of the N-terminal binders (termed “classical inhibitors”), currently in clinical trials, have yet successfully reached the market, because of the detrimental heat shock response (HSR) that showed to induce; thus, recently, the selective inhibition of Hsp90 C-terminal domain has powerfully emerged as a more promising alternative strategy for anti-cancer therapy, not eliciting this cell rescue cascade. However, the structural complexity of the target protein and, mostly, the lack of a co-crystal structure of C-terminal domain-ligand, essential to drive the identification of new hits, represent the largest hurdles in the development of new selective C-terminal inhibitors. Continuing our investigations on the identification of new anticancer drug candidates, by using an orthogonal screening approach, here we describe two new potent C-terminal inhibitors able to induce cancer cell death and a considerable down-regulation of Hsp90 client oncoproteins, without triggering the undesired heat shock response.
Bioorganic & Medicinal Chemistry | 2018
Simone Di Micco; Luana Pulvirenti; Ines Bruno; Stefania Terracciano; Alessandra Russo; Maria C. Vaccaro; Dafne Ruggiero; Vera Muccilli; Nunzio Cardullo; Corrado Tringali; Raffaele Riccio; Giuseppe Bifulco
The natural product magnolol (1) and a selection of its bioinspired derivatives 2-5, were investigated by Inverse Virtual Screening in order to identify putative biological targets from a panel of 308 proteins involved in cancer processes. By this in silico analysis we selected tankyrase-2 (TNKS2), casein kinase 2 (CK2) and bromodomain 9 (Brd9) as potential targets for experimental evaluations. The Surface Plasmon Resonance assay revealed that 3-5 present a good affinity for tankyrase-2, and, in particular, 3 showed an antiproliferative activity on A549 cells higher than the well-known tankyrase-2 inhibitor XAV939 used as reference compound.
Scientific Reports | 2018
Mariaevelina Alfieri; Maria C. Vaccaro; Elisa Cappetta; Alfredo Ambrosone; Nunziatina De Tommasi; Antonietta Leone
Plant abietane diterpenoids (e.g. aethiopinone, 1- oxoaethiopinone, salvipisone and ferruginol), synthesized in the roots of several Salvia spp, have antibacterial, antifungal, sedative and anti-proliferative properties. Recently we have reported that content of these compounds in S. sclarea hairy roots is strongly depending on transcriptional regulation of genes belonging to the plastidial MEP-dependent terpenoid pathway, from which they mostly derive. To boost the synthesis of this interesting class of compounds, heterologous AtWRKY18, AtWRKY40, and AtMYC2 TFs were overexpressed in S. sclarea hairy roots and proved to regulate in a coordinated manner the expression of several genes encoding enzymes of the MEP-dependent pathway, especially DXS, DXR, GGPPS and CPPS. The content of total abietane diterpenes was enhanced in all overexpressing lines, although in a variable manner due to a negative pleiotropic effect on HR growth. Interestingly, in the best performing HR lines overexpressing the AtWRKY40 TF induced a significant 4-fold increase in the final yield of aethiopinone, for which we have reported an interesting anti-proliferative activity against resistant melanoma cells. The present results are also informative and instrumental to enhance the synthesis of abietane diterpenes derived from the plastidial MEP-derived terpenoid pathway in other Salvia species.
Journal of Natural Products | 2018
Ayoub Khalfaoui; Maria Giovanna Chini; Mohamed Bouheroum; Soumia Belaabed; Gianluigi Lauro; Stefania Terracciano; Maria C. Vaccaro; Ines Bruno; Samir Benayache; Ines Mancini; Giuseppe Bifulco
Two new glucopyranosylbianthrones (1 and 2) were isolated from the aerial part of the plant Asphodelus tenuifolius, collected in Southwest Algeria. The 2D structures of 1 and 2 were defined by NMR analysis, HRESIMS data, and comparison with literature data. The comparison of experimental and calculated electronic circular dichroism and NMR data led to characterization of the ( M) and ( P) atropisomeric forms of the glucopyranosylbianthrones, asphodelins (1) and (2), respectively. The in vitro activities of these two metabolites were evaluated in human melanoma A375 cells, and both the compounds inhibited cell proliferation in a concentration-dependent manner, with IC50 values of 20.6 ± 0.8 and 23.2 ± 1.1 μM, respectively. Considering their biological profile, an inverse virtual screening approach was employed to identify and suggest putative anticancer interacting targets.